Adhesion failure during storage – process vs material root cause







Published on 03/01/2026

Addressing Adhesion Failures During Storage: A Comprehensive Investigation Guide

Adhesion failures in pharmaceutical products, particularly in transdermal patches, can pose significant risks, leading to deviations from expected performance and quality. When such failures are noted, it is imperative to conduct a thorough investigation to identify and mitigate underlying causes effectively. This article will provide a detailed step-by-step approach to investigating adhesion failures during storage, enabling professionals to gather meaningful data, perform root cause analysis, and implement effective corrective actions (CAPA).

By following this structured investigation workflow, pharmaceutical professionals will be better equipped to address adhesion-related issues, ensuring compliance with regulatory standards from bodies such as the FDA, EMA, and MHRA while enhancing overall product quality and safety.

Symptoms/Signals on the Floor or in the Lab

Recognizing the signs of adhesion failure is crucial in a timely investigation. Common symptoms on the production floor or

in the laboratory include:

  • Visual Inspection: Observing visible detachment of the adhesive layer from the backing or active layer.
  • Performance Testing: Reduced drug delivery rates during in vitro testing.
  • Storage Incidents: Customer complaints regarding patches losing adhesion during expected shelf life.
  • Batch Variability: Higher than acceptable rates of scrap or out-of-specification (OOS) results attributed to adhesion failures.

Each of these symptoms can trigger a formal investigation. Documenting these signals accurately facilitates the identification of a deviation, enabling teams to quickly initiate assessment protocols.

Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

Identifying potential causes of adhesion failure requires a systematic approach. Here are possible causes categorized effectively:

Category Potential Causes
Materials Incompatible adhesive formulation, expired raw materials, or impurities.
Method Improper application techniques or deviations from SOPs during manufacturing.
Machine Equipment malfunctions or lack of adequate maintenance affecting adhesive application.
Man Human error in procedures, insufficient training, or communication gaps.
Measurement Defective measurement tools leading to incorrect formulation proportions.
Environment Inadequate storage conditions, such as extreme temperatures or humidity levels.

Determining the cause(s) falling under each category can help narrow down the investigation pathway and streamline data collection efforts.

Immediate Containment Actions (first 60 minutes)

Upon identification of an adhesion failure, immediate containment actions should be prioritized to ensure that the issue does not escalate or affect additional batches:

  • Stop Production: Cease operations immediately to prevent further production of potentially defective batches.
  • Quarantine Affected Batches: Isolate any batches that are suspected to exhibit adhesion failures to prevent distribution.
  • Initiate a Recall: If products have been distributed, consider initiating a product recall in alignment with regulatory guidelines.
  • Notify Relevant Departments: Inform quality assurance, regulatory compliance, and product safety teams about the failure.
  • Conduct Visual Assessment: Carry out an immediate visual inspection of all products on the line to assess the scope of the issue.
Pharma Tip:  Backing delamination after adhesive change – CAPA documentation failure

Investigation Workflow (data to collect + how to interpret)

The investigation workflow consists of a series of steps to systematically gather relevant information and derive actionable insights:

  1. Data Collection: Collect data from production logs, batch records, and quality control results. This includes:
    • Adhesive batch-specific data
    • Environmental monitoring data
    • Worker shift logs
    • Equipment maintenance records
  2. Error Trend Analysis: Examine whether adhesion failures have been trending over time and correlate them to specific batches or materials.
  3. Interviews: Conduct interviews with production staff to gather insights into standard operating procedures and potential deviations.
  4. Laboratory Testing: If necessary, initiate fatigue testing or adhesion tests to quantify the failure in adhesive properties.

Data interpretation involves analyzing this evidence to identify any correlation patterns that indicate root causes. Using statistical tools can help to identify trends in adhesion failures associated with specific materials or methods.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

Several root cause analysis tools can aid in clarifying the problem more systematically. This section will outline three different tools:

  • 5-Why Analysis: This technique involves asking “why” repeatedly (usually five times) until the fundamental cause is uncovered. Use this method for more straightforward problems with clear cause-and-effect relationships.
  • Fishbone Diagram (Ishikawa): This tool provides a visual representation of various contributing factors categorized by the six Ms (Materials, Method, Machine, Man, Measurement, Environment). It’s particularly useful when a problem may have multiple causes.
  • Fault Tree Analysis: This quantitative approach is beneficial for complex issues where multiple interactions may exist. By building a logical tree of events leading to the failure, this tool helps visualize the pathways contributing to the adhesion defect.

Choosing the right tool depends on the complexity of the problem and the data available at hand. For example, the 5-Why analysis is exceptionally useful for rapidly identifying root causes, while fault tree analysis can dissect more intricate failure scenarios.

CAPA Strategy (correction, corrective action, preventive action)

A robust CAPA strategy is critical following the investigation to ensure that identified issues do not recur. This three-part strategy consists of:

  • Correction: Address the immediate issue identified by reinstalling a proper adhesive or replacing defective materials.
  • Corrective Action: Identify the root cause and institute changes in the process, such as updating SOPs, retraining personnel, or replacing equipment that contributed to the failure.
  • Preventive Action: Implement long-term measures like regular validation of adhesion methods, conducting periodic training sessions, and enhancing environmental monitoring protocols.
Pharma Tip:  Edge lifting observed during stability pull – CAPA documentation failure

Documentation is essential; all actions taken must be recorded, with specific timelines and responsible individuals assigned to ensure accountability.

Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

After initiating corrective actions, the control strategy should be adapted to monitor stability and quality:

  • Statistical Process Control (SPC): Use SPC techniques to monitor parameters consistently. Employ control charts to identify any shifts indicating deviation risks.
  • Sampling Plans: Implement enhanced sampling plans during production to assess adhesive performance throughout the entire batch lifecycle.
  • Alarms & Alerts: Consider establishing alarms for environmental conditions that affect adhesion, such as temperature and humidity thresholds.
  • Verification: Regularly review the performance metrics post-implementation of corrective actions to evaluate effectiveness.

Validation / Re-qualification / Change Control impact (when needed)

Depending on the findings, validation and re-qualification procedures may require reassessment. Key considerations include:

  • Re-Qualification of Processes and Equipment: Any significant changes resulting from the investigation may necessitate a re-qualification of equipment or processes to ensure conformity.
  • Validation of New Materials: Ensure that new adhesive formulations or materials undergo appropriate validation protocols.
  • Adjustments to Change Control Procedures: Implement rigorous change control measures for materials, suppliers, or processes based on the findings to mitigate risk angles.

Documenting these changes according to regulatory expectations is critical to maintaining compliance and ensuring ongoing quality assurance.

Related Reads

Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

During routine inspections by regulatory bodies such as the FDA, EMA, or MHRA, it is crucial to have relevant documentation readily accessible. Key documents to prepare include:

  • Investigation Records: Documented evidence of the investigation pathways and decisions made.
  • CAPA Documentation: Records that show all corrective and preventive action plans and their implementation timelines.
  • Production and Quality Control Logs: Inspection of batch records and QC logs to verify adherence to specifications.
  • Environment Monitoring Data: Evidence showing compliance with environmental conditions during both production and storage.
  • Training Records: Documentation reflecting staff training related to adhesive application and quality control processes.
Pharma Tip:  Backing delamination after lamination – inspection finding risk

Being fully prepared with clear, evidence-based documentation will not only support compliance but will also demonstrate a commitment to continuous quality improvement.

FAQs

What should I do if I notice an adherence failure in production?

Cease production immediately, quarantine affected batches, and initiate an investigation as per your standard operating procedure (SOP).

What is the most effective root cause analysis tool for adhesion failures?

It depends on the complexity of the issue; consider using 5-Why for straightforward problems and Fishbone diagrams for multi-faceted failures.

How do I document my investigation findings?

Maintain structured records including investigation reports, CAPA actions, and any communications with affected stakeholders.

What are common triggers for adhesion failures in transdermal patches?

Common triggers include expired raw materials, improper environmental control during storage, and deviations from application SOPs.

Is retraining staff necessary after an adhesion failure?

If human error is identified as a contributing factor, retraining staff regarding proper procedures and protocols is essential.

How often should environmental controls be monitored?

Regular monitoring (weekly or monthly, depending on the environment) is necessary for ensuring optimal storage and production conditions.

What type of statistical process control should be used for monitoring adhesion tests?

Use control charts to monitor adhesion test results over time, allowing for early detection of deviations from acceptable performance.

Are there specific regulatory guidelines for addressing adhesion failures?

Yes, refer to guidelines from the FDA, EMA, or MHRA for specific regulatory expectations regarding manufacturing defects and quality assurance protocols.

When should I conduct a re-qualification of my processes?

Re-qualification is necessary if substantial changes in materials, processes, or equipment occur following identified adhesion failures.

How can I ensure that my adhesive formulations remain compliant?

Regularly review supplier materials, conduct in-depth testing, and maintain updated validation documentation to ensure compliance.

What role does CAPA play in preventing future adhesion failures?

CAPA ensures that immediate corrective actions are taken and that preventive measures are implemented to mitigate future risks.

How should I prepare for regulatory inspections after an adhesion failure?

Ensure all documentation related to the investigation, CAPA, and staff training is organized and readily accessible for auditors.

What tools can I use for effective data analysis during the investigation?

Utilize tools such as Excel for data tracking, SPC software for monitoring trends, and specific statistical analysis software for deeper insights.